Middletown, DE -- (SBWIRE) -- 10/07/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Orexigen Therapeutics, Inc.(NASDAQ:OREX), Polycom Inc(NASDAQ:PLCM), Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWD), Extreme Networks, Inc(NASDAQ:EXTR)
Orexigen Therapeutics, Inc.(NASDAQ:OREX) gained volume of 1.34 million shares and the average volume of the stock remained 1.10 million shares. The 52 week range of the stock remained $3.91 - $7.84 and the day range was $6.20 - $6.50.The stock opened the session at $6.43, and closed the session at $6.21. The stock showed a negative performance of -2.82% in previous trading session. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include Contrave, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic.
Has OREX Found The Bottom and Ready To Move Up? Find Out Here
In previous session, Polycom Inc(NASDAQ:PLCM) traded 1.34 million shares and the average volume of the stock remained 2.28 million shares. The 52 week range of the stock remained $9.00 - $11.94. The stock was a bull and advanced +0.27%, while its closing price stayed at $10.95. The market capitalization of the stock remained 1.86 billion. The half-yearly trend of the stock remained positive +1.58%. Polycom, Inc. provides standards-based unified communications and collaboration (UC&C) solutions for voice and video collaboration. The company offers video, voice, and content-management and content-sharing solutions, such as telepresence and conference room systems, home/work office solutions, applications for mobile devices.
For How Long PLCM will fight for Profitability? Read This Trend Analysis report
Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWD) volume of the stock was 1.34 million shares in the most recent session and the average volume remained 1.11 million shares. The stock plunged -1.71% and finished the prior session at the closing price of $11.52. The stock traded 1.34 million shares in its previous trading session and its average volume remained 1.11 million shares. Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, discovers, develops, and commercializes human therapeutic products. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008.
Why Should Investors Buy IRWD After the Recent Fall? Just Go Here and Find Out
Extreme Networks, Inc(NASDAQ:EXTR) traded with volume of 1.34 million shares and the average volume of the stock remained 1.88 million shares. The stock decreased -0.19% and finished the trading at $5.16. The market capitalization of the stock remained 486.33 million. The beta of the stock remained 1.72. Extreme Networks, Inc., together with its subsidiaries, provides network infrastructure equipment and services for enterprises, data centers, and service providers. The company sells its products through distributors, resellers, and its field sales organization. It operates in the United States, Canada, Mexico, Central America, South America, Europe.
Will EXTR Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)